We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Stimulation of S1PR<sub>5</sub> with A-971432, a selective agonist, preserves blood-brain barrier integrity and exerts therapeutic effect in an animal model of Huntington's disease.
- Authors
Di Pardo, Alba; Castaldo, Salvatore; Amico, Enrico; Pepe, Giuseppe; Marracino, Federico; Capocci, Luca; Giovannelli, Alfredo; Madonna, Michele; van Bergeijk, Jeroen; Buttari, Fabio; van der Kam, Elizabeth; Maglione, Vittorio
- Abstract
Huntington's disease (HD) is themost common neurodegenerative disorder for which no effective cure is yet available. Although several agents have been identified to provide benefits so far, the number of therapeutic options remains limited with only symptomatic treatment available. Over the past few years, we have demonstrated that sphingolipid-based approachesmay open the door to newandmore targeted treatments for the disease. In this study, we investigated the therapeutic potential of stimulating sphingosine-1-phosphate (S1P) receptor 5 by the new selective agonist A-971432 (provided by AbbVie) in R6/2 mice, a widely used HD animalmodel. Chronic administration of low-dose (0.1mg/kg) A-971432 slowed down the progression of the disease and significantly prolonged lifespan in symptomatic R6/2 mice. Such beneficial effects were associated with activation of pro-survival pathways (BDNF, AKT and ERK) and with reduction of mutant huntingtin aggregation. A-971432 also protected blood-brain barrier (BBB) homeostasis in the same mice. Interestingly, when administered early in the disease, before any overt symptoms, A-971432 completely protected HDmice fromthe classic progressivemotor deficit and preserved BBB integrity. Beside representing a promising strategy to take into consideration for the development of alternative therapeutic options for HD, selective stimulation of S1P receptor 5may be also seen as an effective approach to target brain vasculature defects in the disease.
- Publication
Human Molecular Genetics, 2018, Vol 27, Issue 14, p2490
- ISSN
0964-6906
- Publication type
Article
- DOI
10.1093/hmg/ddy153